Aroa Soriano
Universitat Autònoma de Barcelona(ES)Vall d'Hebron Institut de Recerca(ES)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Protein Degradation and Inhibitors, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Receptor Mechanisms and Signaling
Most-Cited Works
- → Identification of Dopamine D1–D3 Receptor Heteromers(2008)229 cited
- → Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications(2020)140 cited
- → Adenosine A2AReceptor-Antagonist/Dopamine D2Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2Receptor Heteromers(2009)131 cited
- → ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures(2019)116 cited
- → miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer(2017)103 cited
- → Detection of higher‐order G protein‐coupled receptor oligomers by a combined BRET–BiFC technique(2008)102 cited
- → BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways(2016)93 cited
- → Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling(2009)72 cited
- → microRNAs as pharmacological targets in cancer(2013)56 cited
- → Targeting of epigenetic regulators in neuroblastoma(2018)52 cited